Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study-Reference-Cited by-同舟云学术

Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study

Published:2022-01 Issue:1 Volume:3 Page:100477
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Wesolowska-Andersen Agata^ORCID,Brorsson Caroline A.^ORCID,Bizzotto Roberto^ORCID,Mari Andrea^ORCID,Tura Andrea,Koivula Robert^ORCID,Mahajan Anubha,Vinuela Ana^ORCID,Tajes Juan Fernandez,Sharma Sapna,Haid Mark^ORCID,Prehn Cornelia^ORCID,Artati Anna,Hong Mun-Gwan^ORCID,Musholt Petra B.,Kurbasic Azra^ORCID,De Masi Federico^ORCID,Tsirigos Kostas,Pedersen Helle Krogh^ORCID,Gudmundsdottir Valborg^ORCID,Thomas Cecilia Engel^ORCID,Banasik Karina,Jennison Chrisopher,Jones Angus,Kennedy Gwen^ORCID,Bell Jimmy^ORCID,Thomas Louise^ORCID,Frost Gary,Thomsen Henrik,Allin Kristine^ORCID,Hansen Tue Haldor^ORCID,Vestergaard Henrik,Hansen Torben,Rutters Femke,Elders Petra,t’Hart Leen,Bonnefond Amelie,Canouil Mickaël,Brage Soren^ORCID,Kokkola Tarja^ORCID,Heggie Alison,McEvoy Donna,Hattersley Andrew,McDonald Timothy^ORCID,Teare Harriet,Ridderstrale Martin^ORCID,Walker Mark,Forgie Ian^ORCID,Giordano Giuseppe N.^ORCID,Froguel Philippe,Pavo Imre,Ruetten Hartmut,Pedersen Oluf,Dermitzakis Emmanouil,Franks Paul W.,Schwenk Jochen M.,Adamski Jerzy,Pearson Ewan^ORCID,McCarthy Mark I.,Brunak Søren^ORCID

Funder

Merck

Seventh Framework Programme

Roche

Novo Nordisk Fonden

Sanofi

Innovative Medicines Initiative

AbbVie

National Institute for Health and Care Research

Genentech

Novo Nordisk

National Institute of Diabetes and Digestive and Kidney Diseases